CLOs on the Move

Optogenics Of Syracuse Inc

www.optogenics.com

 
Optogenics Of Syracuse Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

R2 Technologies

Glacial Rx™ is the first age spot removal treatment that uses patented cooling technology to freeze melanin at the source, soothing your skin while effectively removing those annoying age spots.

Cadwell Laboratories

Cadwell is a leading manufacturer and marketer of diagnostic and monitoring products for the world of neurophysiology. We have been proudly serving you since 1979. Visit our online store for all your Electrodes & Accessories needs (US Customers

Orthodontic Supply of Canada

Orthodontic Supply of Canada is a Lincoln, NB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Direct Supply

Direct Supply offers nearly 1 million essential products for healthcare, foodservice, environmental and furnishings, and theyre all eldercare approved.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.